Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Drug eruptions/etiology"'
Autor:
David Almeida, Fernanda Del Rio, Maria Buffara, Maria Alves, Ana L. Sampaio, Alexandre Gripp, Luna Azulay Abulafia
Publikováno v:
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, Vol 80, Iss 1 (2022)
A 35-year-old man with hyperthyroidism reported the sudden occurrence of ulcerated and painful oral lesions, painful ulcerative-necrotic lesions on the face, trunk, upper and lower limbs and purpuric circinate lesions on the scalp, 6 days after start
Externí odkaz:
https://doaj.org/article/143df520a15f495ca6ffae61cc08482b
Autor:
Diogo Diniz Gomes Bugano, Alexandre Biasi Cavalcanti, Anderson Roman Goncalves, Claudia Salvini de Almeida, Eliézer Silva
Publikováno v:
Einstein (São Paulo), Vol 9, Iss 3, Pp 265-282 (2011)
ABSTRACT Objective: To compare efficacy and safety of vancomycin versus teicoplanin in patients with proven or suspected infection. Methods: Data Sources: Cochrane Renal Group's Specialized Register, CENTRAL, MEDLINE, EMBASE, nephrology textbooks and
Externí odkaz:
https://doaj.org/article/d3d74658b539460e9e1ba1af593e9ce7
Autor:
Agnes Triffet, Stef Meers, Ann De Becker, Julie Bekaert, Michael Beck, Koen Van Eygen, Koen Theunissen, Dominik Selleslag, Timothy Devos, Dries Deeren, Hélène Vellemans, Fleur Samantha Benghiat, Benjamin Bailly, Inge Vrelust, Violaine Havelange, Dominiek Mazure, Gaëtan Vanstraelen, Mia Janssen, Nikki Granacher, Philippe Lewalle, Alain Gadisseur
Publikováno v:
Annals of hematology, Vol. 100, no. 7, p. 1723-1732 (2021)
Annals of Hematology
Annals of hematology
ANNALS OF HEMATOLOGY
Annals of Hematology
Annals of hematology
ANNALS OF HEMATOLOGY
Data on clinical use of ponatinib are limited. This prospective registry aimed to evaluate outcomes of ponatinib treatment in routine practice over 3 years (2016–2019) in Belgium (NCT03678454). Patients with chronic myeloid leukemia (CML) or Philad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea5ca85b03c3f75f625c2fd547f3ef52
https://hdl.handle.net/2078.1/246292
https://hdl.handle.net/2078.1/246292
Autor:
Vito Sabato, Michel Verheyden, Didier G. Ebo, Julien Lambert, Margaretha A. Faber, Olivier Aerts
Publikováno v:
Contact Dermatitis. 73:317-320
Keywords: classification; corticosteroids; drug eruption; ear drops; hydrocortisone; methylprednisolone; nose drops; prednisolone; prednisone; screening tests; systemic allergic dermatitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efccedd2e7b4e693c536de4414db4cbf
https://doi.org/10.1111/cod.12442
https://doi.org/10.1111/cod.12442
Autor:
Aysha, Al Malki, Marie-Claude, Marguery, Françoise, Giordano-Labadie, Maria P, Konstantinou, Lorraine, Mokeddem, Laurence, Lamant, Carle, Paul, Aude, Maza, Juliette, Mazereeuw-Hautier
Publikováno v:
Contact Dermatitis
Contact Dermatitis, Wiley, 2017, 76 (3), pp.190-192. ⟨10.1111/cod.12703⟩
Contact Dermatitis, Wiley, 2017, 76 (3), pp.190-192. ⟨10.1111/cod.12703⟩
International audience; Photodynamic therapy (PDT) is used for the treatment ofnon-melanoma skin cancers. A photosensitizer [amino-laevulinic acid (ALA) or methyl aminolaevulinate (MAL)]is applied to the skin and activated by light to producecytotoxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2f4f4402d9918a0f99f3693decdc5cad
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03516704
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03516704
Autor:
Alexandre Biasi Cavalcanti, Eliezer Silva, Anderson R.R. Gonçalves, Diogo Diniz Gomes Bugano, Claudia Salvini de Almeida
Publikováno v:
Einstein (São Paulo), Vol 9, Iss 3, Pp 265-282 (2011)
einstein (São Paulo) v.9 n.3 2011
Einstein (São Paulo)
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
Einstein (São Paulo), Volume: 9, Issue: 3, Pages: 265-282, Published: SEP 2011
einstein (São Paulo) v.9 n.3 2011
Einstein (São Paulo)
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
Einstein (São Paulo), Volume: 9, Issue: 3, Pages: 265-282, Published: SEP 2011
Objective: To compare efficacy and safety of vancomycin versus teicoplanin in patients with proven or suspected infection. Methods: Data Sources: Cochrane Renal Group's Specialized Register, CENTRAL, MEDLINE, EMBASE, nephrology textbooks and review a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a512753e4c4fdad24af55e5b022719
https://doi.org/10.1590/s1679-45082011ao2020
https://doi.org/10.1590/s1679-45082011ao2020
Autor:
Nicolas Ortonne, Judit Horvath, Olivier Chosidow, S Chollet-Martin, S. Grootenboer-Mignot, S. Nahon, Pierre Wolkenstein, C Bernardeschi, Saskia Ingen-Housz-Oro, Emmanuel Laffitte, Chantal Andre
Publikováno v:
British Journal of Dermatology, Vol. 171, No 6 (2014) pp. 1574-1576
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f404c9798542b92818c6eecc159e37
https://doi.org/10.1111/bjd.13153
https://doi.org/10.1111/bjd.13153
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Nexplanon (Schering-Plough Limited/Merck Sharp & Dohme Limited (MSD)) is a long active reversible contraceptive method that provides effective contraception for 3 years. It consists of a single, flexible, rod-shaped implant, containing 68 mg etonoges
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feea1c0cd600651ca1e503a4b4d887aa
https://europepmc.org/articles/PMC4434278/
https://europepmc.org/articles/PMC4434278/
Autor:
Yordanova, Anna, Hose, Dirk, Neben, Kai, Witzens-Harig, Mathias, Gütgemann, Ines, Raab, Marc-Steffen, Moehler, Thomas, Goldschmidt, Hartmut, Schmidt-Wolf, Ingo G H
Sorafenib is a small molecular inhibitor of several tyrosine protein kinases, including vascular endothelial growth factor receptor, platelet-derived growth factor receptor and rapidly accelerated fibrosarcoma kinases, targeting signal transduction a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::41e478693efdab0c737f5aef25939174
https://doi.org/10.1002/hon.2043
https://doi.org/10.1002/hon.2043
Publikováno v:
Acta clinica Croatica
Volume 49
Issue 4
Volume 49
Issue 4
The group of severe cutaneous drug reactions with systemic symptoms includes several syndromes: toxic epidermal necrolysis, Stevens-Johnson syndrome, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______951::7fe711798e4a4a5c009308e9c37014f2
https://hrcak.srce.hr/file/126373
https://hrcak.srce.hr/file/126373